EICHORCondition: Invasive Fungal Infections · Sponsor: Puerta de Hierro University Hospital
Interested? Contact the study team ↓
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The goal of this national multicenter prospective cohort study is to learn about the added value of 18F-FDG (18F-2-fluoro-2-deoxy-D-glucose) PET-CT in invasive fungal disease management. The main questions it aims to answer are: 1. Does the use of 18F-FDG PET-CT allow a better characterization of invasive fungal infection (IFI) (performance) compared to the exclusive use of conventional radiological studies in terms of extension/staging and monitoring of response/follow-up ? 2. Does the systematic and protocolized use of 18F-FDG PET-CT in IFI allow a better management of patients with IFI and increase the prognostic value of the initial evaluation? Participants will undergo systematically a 18F-FDG PET-CT as part of the work-up of their invasive fungal disease. Researchers will compare the performance of 18F-FDG PET-CT with standard management without 18F-FDG PET-CT to see if adds value (diagnostic, prognostic, and changes in management).
This description comes directly from the study's public registry record.
Andrea Gutiérrez Villanueva, MD · +34618157518 · a.gutierrezv@hotmail.com
Begoña Rodríguez Alfonso, MDPhD · +34630078311 · brodrigueza@salud.madrid.org
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion criteria: * 18-year-old adult patients * who are admitted with a diagnosis of invasive fungal infection * who able to undergo a one 18F-FDG PET-CT * who give their informed consent. Exclusion criteria: * concomitant active bacterial infection likely to produce uptake in organs and tissues * recent surgery in the area of the IFI (in the previous 3 months) * other medical conditions that interfere with the development of the study ( e.g., inability to tolerate the performance of the test during the required time, pregnancy) * terminal situation.
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Hospital Universitario Puerta de Hierro | Majadahonda, Madriid, Spain | Recruiting |
| Hospital de Bellvitge | Barcelona, Spain | Recruiting |
| Hospital Universitario Clinic | Barcelona, Spain | Recruiting |
| Hospital Universitario Virgen de las Nieves | Granada, Spain | Recruiting |
| Hospital Infanta Leonor Hospital | Madrid, Spain | Recruiting |
| Hospital Universitario Gregorio Marañón | Madrid, Spain | Recruiting |
| Hospital Universitario La Paz | Madrid, Spain | Recruiting |
| Hospital Unversitario Ramón y Cajal | Madrid, Spain | Recruiting |
| Hospital Virgen de la Victoria | Málaga, Spain | Recruiting |
| Hospital Morales Messeguer | Murcia, Spain | Not Yet Recruiting |
| Hospital Virgen de la Arrixaca | Murcia, Spain | Not Yet Recruiting |
| Hospital Universitario Central de Asturias | Oviedo, Spain | Recruiting |
+ 2 more locations — full list on the registry record.
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05688592